(Q37682514)

22 August 2017

1 reference

title

Guidance for substantiating the evidence for beneficial effects of probiotics: prevention and management of infections by probiotics (English)

1 reference

22 August 2017

0 references

3

Eveliina Myllyluoma

0 references

Hania Szajewska

object named as

Hania Szajewska

5

0 references

author name string

Danielle Wolvers

1

1 reference

22 August 2017

Jean-Michel Antoine

2

1 reference

22 August 2017

Eveliina Myllyluoma

3

1 reference

22 August 2017

Juergen Schrezenmeir

4

1 reference

22 August 2017

Ger T Rijkers

6

1 reference

22 August 2017

language of work or name

English

0 references

publication date

27 January 2010

1 reference

22 August 2017

1 reference

22 August 2017

volume

140

1 reference

22 August 2017

issue

3

1 reference

22 August 2017

page(s)

698S-712S

1 reference

22 August 2017

cites work

Colonization resistance

1 reference

https://api.crossref.org/works/10.3945%2FJN.109.113753

Probiotics in the treatment and prevention of acute infectious diarrhea in infants and children: a systematic review of published randomized, double-blind, placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.109.113753

Lactobacillus therapy for acute infectious diarrhea in children: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.109.113753

Effect of Lactobacillus gasseri PA 16/8, Bifidobacterium longum SP 07/3, B. bifidum MF 20/5 on common cold episodes: a double blind, randomized, controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.109.113753

Increasing work-place healthiness with the probiotic Lactobacillus reuteri: a randomised, double-blind placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.109.113753

Effect of a probiotics supplementation on respiratory infections and immune and hormonal parameters during intense military training

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.109.113753

Effect of a probiotic infant formula on infections in child care centers: comparison of two probiotic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.109.113753

Efficacy of Bacillus clausii spores in the prevention of recurrent respiratory infections in children: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.109.113753

Probiotics in the prevention of antibiotic-associated diarrhea in children: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.109.113753

Probiotics for pediatric antibiotic-associated diarrhea: a meta-analysis of randomized placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.109.113753

Probiotics in prevention of antibiotic associated diarrhoea: meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.109.113753

Meta-analysis: the effect of probiotic administration on antibiotic-associated diarrhoea.

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.109.113753

Meta-analysis: non-pathogenic yeast Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.109.113753

Is Lactobacillus rhamnosus GG effective in preventing the onset of antibiotic-associated diarrhoea: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.109.113753

Efficacy of probiotics in prevention of acute diarrhoea: a meta-analysis of masked, randomised, placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.109.113753

Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.109.113753

Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: randomised double blind placebo controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.109.113753

Bifidobacterium longum PL03, Lactobacillus rhamnosus KL53A, and Lactobacillus plantarum PL02 in the prevention of antibiotic-associated diarrhea in children: a randomized controlled pilot trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.109.113753

Probiotic therapy for the prevention and treatment of Clostridium difficile-associated diarrhea: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.109.113753

Probiotics for prevention of necrotising enterocolitis in preterm neonates with very low birthweight: a systematic review of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.109.113753

Oral probiotics prevent necrotizing enterocolitis in very low birth weight preterm infants: a multicenter, randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.109.113753

Efficacy of Lactobacillus GG as a Diarrheal Preventive in Travelers

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.109.113753

Prevention of travellers' diarrhoea by Lactobacillus GG.

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.109.113753

Oral administration of probiotic Escherichia coli after birth reduces frequency of allergies and repeated infections later in life (after 10 and 20 years).

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.109.113753

Effect of Lactobacillus GG supplementation on antibiotic-associated gastrointestinal side effects during Helicobacter pylori eradication therapy: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.109.113753

Impact of supplement with Lactobacillus- and Bifidobacterium-containing yogurt on triple therapy for Helicobacter pylori eradication

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.109.113753

Effect of different probiotic preparations on anti-helicobacter pylori therapy-related side effects: a parallel group, triple blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.109.113753

Effects of a specially designed fermented milk product containing probiotic Lactobacillus casei DN-114 001 and the eradication of H. pylori in children: a prospective randomized double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.109.113753

Probiotic supplementation improves tolerance to Helicobacter pylori eradication therapy--a placebo-controlled, double-blind randomized pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.109.113753

Lactobacillus reuteri therapy to reduce side-effects during anti-Helicobacter pylori treatment in children: a randomized placebo controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.109.113753

Efficacy and safety of Saccharomyces boulardii in the 14-day triple anti-Helicobacter pylori therapy: a prospective randomized placebo-controlled double-blind study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.109.113753

Effect of whey-based culture supernatant of Lactobacillus acidophilus (johnsonii) La1 on Helicobacter pylori infection in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.109.113753

Favourable effect of an acidified milk (LC-1) on Helicobacter pylori gastritis in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.109.113753

Lack of therapeutic effect of a specially designed yogurt for the eradication of Helicobacter pylori infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.109.113753

Effect of the ingestion of a dietary product containing Lactobacillus johnsonii La1 on Helicobacter pylori colonization in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.109.113753

Favourable effect of regular intake of fermented milk containing Lactobacillus johnsonii on Helicobacter pylori associated gastritis

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.109.113753

Effect of frequent consumption of a Lactobacillus casei-containing milk drink in Helicobacter pylori-colonized subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.109.113753

Inhibition of Helicobacter pylori infection in humans by Lactobacillus reuteri ATCC 55730 and effect on eradication therapy: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.109.113753

Probiotics for treatment of acute diarrhoea in children: randomised clinical trial of five different preparations

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.109.113753

Meta-analysis: Lactobacillus GG for treating acute diarrhoea in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.109.113753

Clinical practice. Antibiotic-associated diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.109.113753

Meta-analysis of probiotics for the prevention of traveler's diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.109.113753

Stool microflora in extremely low birthweight infants

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.109.113753

Fecal microbial community in preterm infants

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.109.113753

Oral probiotics prevent necrotizing enterocolitis in very low birth weight neonates

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.109.113753

Effect of probiotics on preventing disruption of the intestinal microflora following antibiotic therapy: a double-blind, placebo-controlled pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.109.113753

Effects of probiotics on the composition of the intestinal microbiota following antibiotic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.109.113753

The role of bacterial interference in otitis, sinusitis and tonsillitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.109.113753

Early enteral supply of fiber and Lactobacilli versus conventional nutrition: a controlled trial in patients with major abdominal surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.109.113753

Supply of pre- and probiotics reduces bacterial infection rates after liver transplantation--a randomized, double-blind trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.109.113753

A prospective randomised study of the probiotic Lactobacillus plantarum 299V on indices of gut barrier function in elective surgical patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.109.113753

Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.109.113753

Markers to measure immunomodulation in human nutrition intervention studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.109.113753

OMICS-derived targets for inflammatory gut disorders: opportunities for the development of nutrition related biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.109.113753

A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.109.113753

Tolerance and Efficacy of Interfering Alpha-streptococci in Recurrence of Streptococcal Pharyngotonsillitis: a Placebo-controlled Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.109.113753

A lyophilized and inactivated culture of Lactobacillus acidophilus increases Helicobacter pylori eradication rates

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.109.113753

The effect of oral administration of Lactobacillus GG on antibiotic-associated gastrointestinal side-effects during Helicobacter pylori eradication therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.109.113753

21 January 2018

Identifiers

DOI

10.3945/JN.109.113753

1 reference

22 August 2017

1 reference